| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Frisco Holding II | 10%+ Owner | 3100 WEST END AVENUE, NASHVILLE | /s/ J. William B. Morrow, President | 10 Feb 2026 | 0001433317 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HCA | Common Stock, par value $0.01 per share | Other | -36,629,188 | -100% | 0 | 06 Feb 2026 | Direct | F1, F2, F3 | ||
| transaction | HCA | Common Stock, par value $0.01 per share | Other | +36,557,141 | 36,557,141 | 06 Feb 2026 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | On February 6, 2026, the Reporting Person disposed of 36,629,188 shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer"), in exchange for 36,557,141 Shares newly issued by the Issuer to the Reporting Person, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of the Reporting Person to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended. |
| F2 | The Reporting Person is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. |
| F3 | The Shares disposed of were previously reported by the Reporting Person as indirectly beneficially owned through Hercules Holding II ("Hercules"). Prior to the disposition reported in this filing, those shares were distributed for no consideration and on a pro rata basis by Hercules, effecting a change in form of beneficial ownership without changing the Reporting Person's pecuniary interest. |